UP!

TRVN $0.46

TRVN target price
0.46
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2022 2022-11-14 Future report Set alerts
Q2 2022 2022-08-11 -0.09 -0.09
Q1 2022 2022-05-11 -0.10 -0.10
Q4 2021 2022-03-31 -0.08 -0.08
Q3 2021 2021-11-15 -0.08 -0.08
Q2 2021 2021-08-12 -0.09 -0.09
Q1 2021 2021-05-06 -0.06 -0.06
Q4 2020 2021-03-09 -0.08 -0.08
Q3 2020 2020-11-02 -0.04 -0.04
Q2 2020 2020-08-10 -0.06 -0.06

Ratings

2016-06-02 Reiterated Rating Cowen and Company Buy
2016-05-17 Reiterated Rating Wedbush Outperform $20.00 to $16.00
2016-05-17 Reiterated Rating Needham & Company LLC Buy $14.00 to $11.00
2016-05-17 Boost Price Target FBR & Co. Outperform $13.00 to $16.00
2016-05-17 Boost Price Target FBR & Co Outperform $13.00 to $16.00
2016-05-16 Reiterated Rating Brean Capital Buy
2016-05-16 Reiterated Rating Cowen and Company Buy
2016-05-14 Reiterated Rating FBR & Co. Buy
2016-05-05 Reiterated Rating Wedbush Outperform $20.00
2016-05-04 Reiterated Rating FBR & Co. Buy $16.00
2016-05-03 Reiterated Rating Needham & Company LLC Buy
2016-05-03 Reiterated Rating Brean Capital Buy
2016-05-03 Reiterated Rating Cowen and Company Buy
2016-04-17 Reiterated Rating Cowen and Company Buy
2016-04-07 Reiterated Rating Wedbush Positive
2016-03-29 Initiated Coverage FBR & Co. Outperform $16.00
2016-03-22 Reiterated Rating Needham & Company LLC Buy $14.00
2016-03-15 Reiterated Rating Cowen and Company Buy
2016-03-10 Reiterated Rating Brean Capital Buy $14.00
2016-03-09 Reiterated Rating Wedbush Outperform $20.00
2016-03-09 Lower Price Target JMP Securities Market Outperform $21.00 to $18.00
2016-03-02 Initiated Coverage WallachBeth Capital Buy $18.00
2016-02-24 Lower Price Target Barclays Overweight $18.00 to $15.00
2016-02-24 Lower Price Target Barclays PLC Overweight $18.00 to $15.00
2016-02-23 Reiterated Rating Jefferies Group Buy $15.00
2016-02-22 Reiterated Rating Cowen and Company Outperform $14.00
2016-02-22 Reiterated Rating Wedbush Outperform $20.00
2015-11-17 Reiterated Rating Wedbush Outperform $20.00
2015-11-11 Reiterated Rating Needham & Company LLC Buy $14.00
2015-11-01 Reiterated Rating Needham & Company LLC Buy $14.00
2015-10-29 Initiated Coverage Brean Capital Buy
2015-09-02 Reiterated Rating JMP Securities Buy
2015-09-02 Reiterated Rating Roth Capital Buy
2015-09-02 Reiterated Rating Wedbush Buy
2015-09-02 Boost Price Target Jefferies Group Buy $9.00 to $13.00
2015-09-01 Reiterated Rating Cowen and Company Buy $13.00 to $14.00
2015-09-01 Upgrade Barclays Equal Weight to Overweight $11.00 to $18.00
2015-09-01 Reiterated Rating Needham & Company LLC Buy to Positive $14.00
2015-09-01 Boost Price Target Wedbush Outperform $15.00 to $20.00
2015-08-11 Reiterated Rating Needham & Company LLC Buy $14.00
2015-08-11 Reiterated Rating Brean Capital Buy $14.00
2015-08-03 Initiated Coverage Brean Capital Buy $14.00
2015-07-09 Reiterated Rating Wedbush Buy $15.00
2015-06-16 Initiated Coverage Roth Capital Buy $14.50
2015-05-21 Initiated Coverage Barclays Equal Weight $11.00
2015-05-08 Lower Price Target Jefferies Group Buy $11.00 to $9.00
2015-05-07 Set Price Target Needham & Company LLC Buy $14.00
2015-03-31 Initiated Coverage Wedbush Outperform $15.00
2015-03-24 Reiterated Rating Cowen and Company Outperform $13.00
2014-12-19 Initiated Coverage Cowen and Company Outperform $13.00
2014-11-18 Boost Price Target JMP Securities Outperform $18.00 to $21.00
2014-11-18 Reiterated Rating Needham & Company LLC Positive
2014-02-27 Initiated Coverage Needham & Company LLC Buy $14.00
2014-02-26 Initiated Coverage JMP Securities Outperform $18.00
2014-02-26 Initiated Coverage Barclays Overweight $14.00
2014-02-26 Initiated Coverage Jefferies Group Buy $11.00
2016-06-02 Reiterated Rating Cowen and Company Buy
2016-05-17 Reiterated Rating Wedbush Outperform $20.00 to $16.00
2016-05-17 Reiterated Rating Needham & Company LLC Buy $14.00 to $11.00
2016-05-17 Boost Price Target FBR & Co. Outperform $13.00 to $16.00
2016-05-17 Boost Price Target FBR & Co Outperform $13.00 to $16.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
New Enterprise Associates 12, Limited Partnership 18.25%  (4811691) ARDX / ECHO / ECOM / HPTX / OPWR / TNTR / TRVN / ZSAN /
Alta Partners VIII, L.P. 16.65%  (4390262) AGTC / ESPR / IMDZ / NEOT / TRVN / ZSPH /
Forest Laboratories Holdings Ltd 12.87%  (3393466) FRX / TRVN /
HealthCare Ventures VIII, L.P. 9.28%  (2446251) TRVN /
GOWEN MAXINE President & CEO 0.74%  (195512) AKBA / IDRA / TRVN /
Lark Michael W. Sr. VP, Research & CSO 0.37%  (98460) TRVN /
MOULDER LEON O JR 0.19%  (50000) CBST / TRVN / TSRO /
Polaris Venture Management Co. V, L.L.C. 0.14%  (36369) BIND / CERU / FATE / GNCA / TRVN /
Deegan Rosamond Sr VP, Bus Dev & Operations 0.12%  (31105) TRVN /
Cuca Roberto Sr. VP and CFO 0.09%  (25000) TRVN /
Limongelli John M Sr. VP,General Counsel & Secy 0.05%  (12000) TRVN /
DOUGHERTY MICHAEL R 0.03%  (7000) BOTA / CEMP / CPXX / FMI / MRNS / TRVN / VPHM /
Nunn Jason Raleigh 0.02%  (4271) DERM / HPTX / TRVN / TSPT /
Soergel David Sr. VP, Clinical Development 0.01%  (1750) TRVN /